Asosiy kontentga oʻtish
Maqola

Association of MRI Indices of Glymphatic System With Amyloid Deposition and Cognition in Mild Cognitive Impairment and Alzheimer Disease

Koji KamagataFaculty of Health Data Science (C.A.), Juntendo University, Urayasu, Chiba, Department of Innovative Biomedical Visualization (iBMV) (T.T.), Nagoya University Graduate School of Medicine, Shouwa-ku, NagoyaChristina AndicaDepartment of Radiology (Kouhei Kamiya, M.H.), Toho University Omori Medical Center, Ota-ku, TokyoKaito TakabayashiDepartment of Radiology (S.N.), Nagoya University Graduate School of Medicine, Shouwa-ku, Nagoya, JapanYuya SaitoFaculty of Health Data Science (C.A.), Juntendo University, Urayasu, Chiba, Department of Innovative Biomedical Visualization (iBMV) (T.T.), Nagoya University Graduate School of Medicine, Shouwa-ku, NagoyaToshiaki TaokaDepartment of Radiology (Kouhei Kamiya, M.H.), Toho University Omori Medical Center, Ota-ku, TokyoHayato NozakiDepartment of Radiology (S.N.), Nagoya University Graduate School of Medicine, Shouwa-ku, Nagoya, JapanJunko KikutaFrom the Department of Radiology (Koji Kamagata, C.A., K.T., Y.S., H.N., J.K., S.F., A.H., A.W., T.A., K.S., M.N., S.A.), Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo; Faculty of Health Data Science (C.A.), Juntendo University, Urayasu, Chiba, Department of Innovative Biomedical Visualization (iBMV) (T.T.), Nagoya University Graduate School of Medicine, Shouwa-ku, Nagoya; Department of Radiology (Kouhei Kamiya, M.H.), Toho University Omori Medical Center, Ota-ku, Tokyo; andShohei FujitaFaculty of Health Data Science (C.A.), Juntendo University, Urayasu, Chiba, Department of Innovative Biomedical Visualization (iBMV) (T.T.), Nagoya University Graduate School of Medicine, Shouwa-ku, NagoyaAkifumi HagiwaraFaculty of Health Data Science (C.A.), Juntendo University, Urayasu, Chiba, Department of Innovative Biomedical Visualization (iBMV) (T.T.), Nagoya University Graduate School of Medicine, Shouwa-ku, NagoyaKouhei KamiyaDepartment of Radiology (S.N.), Nagoya University Graduate School of Medicine, Shouwa-ku, Nagoya, JapanAkihiko WadaDepartment of Radiology (S.N.), Nagoya University Graduate School of Medicine, Shouwa-ku, Nagoya, JapanToshiaki AkashiFrom the Department of Radiology (Koji Kamagata, C.A., K.T., Y.S., H.N., J.K., S.F., A.H., A.W., T.A., K.S., M.N., S.A.), Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo; Faculty of Health Data Science (C.A.), Juntendo University, Urayasu, Chiba, Department of Innovative Biomedical Visualization (iBMV) (T.T.), Nagoya University Graduate School of Medicine, Shouwa-ku, Nagoya; Department of Radiology (Kouhei Kamiya, M.H.), Toho University Omori Medical Center, Ota-ku, Tokyo; andKatsuhiro SanoDepartment of Radiology (S.N.), Nagoya University Graduate School of Medicine, Shouwa-ku, Nagoya, JapanMitsuo NishizawaDepartment of Radiology (S.N.), Nagoya University Graduate School of Medicine, Shouwa-ku, Nagoya, JapanMasaaki HoriDepartment of Radiology (Kouhei Kamiya, M.H.), Toho University Omori Medical Center, Ota-ku, TokyoShinji NaganawaDepartment of Radiology (S.N.), Nagoya University Graduate School of Medicine, Shouwa-ku, Nagoya, JapanShigeki AokiFaculty of Health Data Science (C.A.), Juntendo University, Urayasu, Chiba, Department of Innovative Biomedical Visualization (iBMV) (T.T.), Nagoya University Graduate School of Medicine, Shouwa-ku, Nagoyafor the Alzheimer's Disease Neuroimaging InitiativeFrom the Department of Radiology (Koji Kamagata, C.A., K.T., Y.S., H.N., J.K., S.F., A.H., A.W., T.A., K.S., M.N., S.A.), Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo; Faculty of Health Data Science (C.A.), Juntendo University, Urayasu, Chiba, Department of Innovative Biomedical Visualization (iBMV) (T.T.), Nagoya University Graduate School of Medicine, Shouwa-ku, Nagoya; Department of Radiology (Kouhei Kamiya, M.H.), Toho University Omori Medical Center, Ota-ku, Tokyo; and Department of Radiology (S.N.), Nagoya University Graduate School of Medicine, Shouwa-ku, Nagoya, Japan
2022en
ABI

Annotatsiya

<h3>Background and Objectives</h3> The glymphatic system is a whole-brain perivascular network, which promotes CSF/interstitial fluid exchange. Alterations to this system may play a pivotal role in amyloid β (Aβ) accumulation. However, its involvement in Alzheimer disease (AD) pathogenesis is not fully understood. Here, we investigated the changes in noninvasive MRI measurements related to the perivascular network in patients with mild cognitive impairment (MCI) and AD. Additionally, we explored the associations of MRI measures with neuropsychological score, PET standardized uptake value ratio (SUVR), and Aβ deposition. <h3>Methods</h3> MRI measures, including perivascular space (PVS) volume fraction (PVSVF), fractional volume of free water in white matter (FW-WM), and index of diffusivity along the perivascular space (ALPS index) of patients with MCI, those with AD, and healthy controls from the Alzheimer9s Disease Neuroimaging Initiative database were compared. MRI measures were also correlated with the levels of CSF biomarkers, PET SUVR, and cognitive score in the combined subcohort of patients with MCI and AD. Statistical analyses were performed with age, sex, years of education, and <i>APOE</i> status as confounding factors. <h3>Results</h3> In total, 36 patients with AD, 44 patients with MCI, and 31 healthy controls were analyzed. Patients with AD had significantly higher total, WM, and basal ganglia PVSVF (Cohen <i>d</i> = 1.15–1.48; <i>p</i> &lt; 0.001) and FW-WM (Cohen <i>d</i> = 0.73; <i>p</i> &lt; 0.05) and a lower ALPS index (Cohen <i>d</i> = 0.63; <i>p</i> &lt; 0.05) than healthy controls. Meanwhile, the MCI group only showed significantly higher total (Cohen <i>d</i> = 0.99; <i>p</i> &lt; 0.05) and WM (Cohen <i>d</i> = 0.91; <i>p</i> &lt; 0.05) PVSVF. Low ALPS index was associated with lower CSF Aβ42 (<i>r</i><sub><i>s</i></sub> = 0.41, <i>p</i><sub><i>fdr</i></sub> = 0.026), FDG-PET uptake (<i>r</i><sub><i>s</i></sub> = 0.54, <i>p</i><sub><i>fdr</i></sub> &lt; 0.001), and worse multiple cognitive domain deficits. High FW-WM was also associated with lower CSF Aβ42 (<i>r</i><sub><i>s</i></sub> = −0.47, <i>p</i><sub><i>fdr</i></sub> = 0.021) and worse cognitive performances. <h3>Discussion</h3> Our study indicates that changes in PVS-related MRI parameters occur in MCI and AD, possibly due to impairment of the glymphatic system. We also report the associations between MRI parameters and Aβ deposition, neuronal change, and cognitive impairment in AD.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba